Randox in the Racing World - Sensitive Screening Solutions
News Mar 23, 2009
Randox supply a comprehensive range of diagnostic solutions for the detection of prohibited substances in international racing.
Randox have developed a new novel screening technology known as Biochip Array Technology. This latest revolution from Randox can be used for testing samples from Equine and Canine racing samples. Randox Biochip Array Technology is a screening system which enables simultaneous testing of multiple analytes using one single sample. It is a technology based on ELISA principles - but rather than binding antibodies to a microtitre plate the analytes are bound to a 9mm x 9mm Biochip on different X Y co-ordinates. Randox offer a wide portfolio of drugs of abuse, growth promoters, synthetic steroids and their metabolites.
Randox also have a comprehensive range of ELISA kits which includes Beta-agonists, Boldenone, Corticosteroids, 19-Nortestosterone/Trenbolone, Ractopamine, Stanozolol, Trenbolone, Phenylbutazone and Zeranol, with the release of a Flunixin and Ketamine ELISA coming soon. All kits offer excellent limits of detection, a wide range of sample matrices, small sample volume and outstanding cross reactivity.
To complement our range of screening tests Randox have developed a range of immunoaffinity columns for sample purification prior to sample analysis by screening or confirmatory technology such as GC/MS, LC/MS. Randox immunoaffinity columns are efficient, whilst also being cost-effective and convenient. Available columns have long shelf lives and come with equilibration and storage buffers. Available columns include Clenbuterol/ß-agonists, Corticosteroids, Trenbolone and 19-Nortestosterone, Stilbene, Zeranol and our new multi-analyte Growth Promoter column.
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Simple Sugar Prevents Neurodegeneration in Lysosomal Storage DiseaseNews
New therapeutic approach may one day delay neurodegeneration typical of a disease called mucopolysaccharidoses IIIB (MPS IIIB)READ MORE
Eating Activates Calorie-Burning FatNews
The importance of the human brown adipose tissue (BAT) has become clearer during the past ten years. Coldness is one of the most effective activators of the BAT metabolic function but, in rodents, eating has also been shown to activate BAT. The debate on whether eating has the same effect on humans has lasted for decades. Now, the researchers at Turku PET Centre have proven that having a meal increases oxygen consumption in human BAT to the same extent as coldness.READ MORE